Diversity In Clinical Trials: Is DEI Dead?
Source: Clinical Leader
Despite political headwinds and policy rollbacks, the need for diversity in clinical trials is as urgent as ever. This expert panel discussed the current landscape, the real impact of recent setbacks, and why equitable patient recruitment must remain a priority.
Panelists included:
- Camille (Pope) Campbell — Lead, Health Equity & Clinical Innovation, Biogen;
- Jessica Brescher — Director of Clinical Sciences, Tectonic Therapeutic; and
- Jennifer Miller — CoDirector, Program for Biomedical Ethics, Associate Professor, Yale School of Medicine.
access the Virtual Event!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader